Page last updated: 2024-10-28

guanethidine and Anemia, Hemolytic

guanethidine has been researched along with Anemia, Hemolytic in 1 studies

Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zimmerman, SW1
Bergin, JJ1

Other Studies

1 other study available for guanethidine and Anemia, Hemolytic

ArticleYear
Heparin therapy for the renal disease of malignant hypertension.
    Nephron, 1974, Volume: 12, Issue:3

    Topics: Adult; Anemia, Hemolytic; Creatinine; Dipyridamole; Female; Guanethidine; Hematoma; Heparin; Humans;

1974